4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-011614
Chief Business Officer sold 12,500 shares at an average $24.67 ($308,428)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2022-03-17 | Sale | −7,512 | $24.68 | $185,374 | 76,434 | D |
| Robb Gary Charles Chief Business Officer | 2022-03-18 | Sale | −4,988 | $24.67 | $123,054 | 71,446 | D |
| Open-market sales · 12,500 sh · avg $24.67 · $308,428 | |||||||
Loading xslF345X03/doc4.xml…